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Abstract 
Currently, approximately 30% of epileptic patients treated with antiepileptic drugs (AEDs) remain resistant to 
treatment (known as refractory patients). This project seeks to understand the underlying similarities in refractory 
patients vs. other epileptic patients, identify features contributing to drug resistance across underlying phenotypes 
for refractory patients, and develop predictive models for drug resistance in epileptic patients. 
 
In this study, epileptic patient data was examined to attempt to observe discernable similarities or differences in 
refractory patients (case) and other non-refractory patients (control) to map underlying mechanisms in causality. 
For the first part of the study, unsupervised algorithms such as Kmeans, Spectral Clustering, and Gaussian Mixture 
Models were used to examine patient features projected into a lower dimensional space. Results from this study 
showed a high degree of non-linearity in the underlying feature space. For the second part of this study, 
classification algorithms such as Logistic Regression, Gradient Boosted Decision Trees, and SVMs, were tested on 
the reduced-dimensionality features, with accuracy results of 0.83(+/-0.3) testing using 7 fold cross validation.  
Observations of test results indicate using a radial basis function kernel PCA to reduce features ingested by a 
Gradient Boosted Decision Tree Ensemble lead to gains in improved accuracy in mapping a binary decision to 
highly non-linear features collected from epileptic patients 
Introduction and Motivation 
As rapid advances are made in the field of machine learning and big data, researchers are turning to these tools to 
develop a means to predict outcomes for patient treatment. Within the area of epilepsy research, there is much 
interest in understanding the underlying causes for failures in surgical treatments, as well as failures in antiepileptic 
drug treatments for patients.  
Specific interest in finding the right treatment to combat intractable epilepsy remains at the forefront of current 
research. Intractable epilepsy, where there is little to no control over seizures using medications, can have a major 
effect on a patient’s quality of life.  Patients may have trouble with work or school, and may obtain injuries as the 
result of unpredictable onsets. Additionally, Pardoe HR et al. showed that intractable epilepsy might advance brain 
aging by up to 9 years [4].  Loescher et.al describe various hypotheses for causality for drug resistance, in particular 
the gene variant hypothesis, where it has been shown the P-glycoprotein, which is regulated by the ABCB1 gene, 
may play a role in drug resistance [3]. 
In regards to applying machine learning techniques for classification and causality discovery, the evidence is sparse 
in the literature. Hernández-Ronquillo et.al showed that some features of refractory patients might have predictive 
quality when used for a logistic regression analysis [6]. 
Problem Formulation 
For this study, two hypotheses were developed: 
1. Clustering techniques and/or graph analysis and algorithms may be used to effectively model the distinct 
segments in refractory patients and other epileptic patients in remission. Underlying phenotypes in 
refractory patients may be identified and clustered. 
2. Significant classification accuracy for patients likely to develop drug resistance may be established and 
refined by predictive modeling. 
 
Metrics for evaluation for classifiers included AUC and Cross-Validation Accuracy. Metrics for clustering included 
adjusted rand score and adjusted mutual information. 
For training, K-fold Cross-Validation was used to partition training samples into k folds, and retained k-1 partitions 
as training data. This process was repeated for k times, with each of the folds held out as validation data. The final 
estimation was calculated as the averaged accuracy of the estimator for each fold. For this study 7-fold cross 
validation was used. 
  
In cohort construction, features for epileptic patients were indexed by the date of first failure, and events (diagnoses, 
procedures, etc.) occurring previous to the index date were aggregated as features for ingestion by the unsupervised 
and supervised machine learning models. Patients with 4 or more future failures were considered as case, with 
control being epileptic patients with only one AED failure with no future failure. As the Events3 dataset was quite 
large, case and control patients were sampled from larger populations.  
 
Figure 1: Cohort Construction 
In sampling from the Events3 dataset, which was over 19gb in size, 58800 distinct refractory patients (case) were 
observed. From this population, 2000 case patients and 2000 control patients were subsampled to create balanced 
classes for the estimators. The raw features in the data contained over 20624 attributes, which when reduced using 
Kernel PCA, resulted in 6600 attributes of events. 
In the case of feature selection, filtered events for case and control were transposed to create a row-wise feature 
matrix per patient. In this study little feature engineering was intentionally done as to evaluate the performance of 
unsupervised feature extraction: 
1. 𝑥 =    !!....!!  
2. X = 𝑥!!!!!  
 
 
 
Approach and Implementation 
For this project, Spark 1.6 and Hadoop were configured on Google Cloud Dataproc, with Jupyter notebook 
integration. Data manipulation, aggregation, cleaning were completed using Spark SQL DataFrames, and 
machine learning models were developed and tested using scikit –learn in Python. 
In setting up a Big Data environment, 1 High memory 32gb master node with 3 4gb worker nodes were 
provisioned. As this was a trial environment, there were limitations on the ability to scale out- or provision more 
worker nodes dynamically, which resulted in longer compute times. For all of the Spark SQL dataframe 
operations for example, the average compute time was around 6 hours on the event3 dataset. 
 
  
  
Experiment Design  
For the first hypothesis, unsupervised algorithms were run over the data to investigate accuracy in clustering 
techniques. In addition to running clustering algorithms over the raw features of the data, dimensionality reduction 
algorithms were used to project the data into lower dimensional spaces to investigate clustering efficacy. 
The results did not show any significant accuracy of the clustering algorithms to find distinct cluster, both in the 
normal and reduced dimension spaces. 
 
Figure 2: Results from Clustering algorithms tested  for hypothesis 1. 
 
For hypothesis 2, a group of classification algorithms were tested to evaluate estimator performance on data reduced 
by Kernel PCA. 
 
Figure 3: ROC Chart for Estimators trained on Kernel PCA reduced data.  
 
  
 
In reviewing estimator performance over the reduced dataset, Tree-based classifiers, such as Decision Tree, 
ADABoost, and Ensemble Gradient Boosted Tress were observed to have the greatest AUC. An explanation for this 
could be that tree-based classifiers could capture the data that were non-linearly separable, thereby increasing 
performance. Where the decision boundary of the linear and kernel support vector machines and other distance-
based classifiers did not capture the underlying non-linear quality in the data  
Kernel PCA 
Kernel PCA is a variation of standard Principal Components Analysis- where instead of extracting the eigenvectors 
of the largest eigenvalues of the covariance matrix: 
3. 𝑋′ =    !! 𝑥!!!!!   𝑥!𝑇 
The data is mapped into a higher dimensional space by a kernel function. This variation is also known as the “kernel 
trick”: 
4. 𝑋′ =    !! 𝜙(𝑥!  !!!! )𝜙(𝑥!)𝑇 
In investigation for best hyperparameter selection: 𝛾 is the parameter adjusted, given by: 
5. 𝜙 𝑥! , 𝑥!   =   exp  (  −𝛾   𝑥! −   𝑥!     !  !   ) 
In this Study, Gradient Boosted Decision Trees were observed to have significant classification accuracy. 
 
Gradient Boosted Decision Trees 
GBDT trains additive models of weak learners  in a forward stage-wise fashion, where at each stage,  weak learners 
are chosen to minimize a given loss function ℒ given the current model and fit. 
6. 𝐹! 𝑋! = 𝐹  !!! 𝑋! + arg   min!       ℒ(  !!!! 𝑦! ,𝐹  !!! 𝑋′! − ℎ(𝑋′)) 
 
  
The negative gradient of the loss function is minimized until convergence, which is given by 𝛼, where 𝛼 is the 
hyperparameter to optimize: 
7. 𝛼′ = arg   min!       ℒ(  !!!! 𝑦! ,𝐹  !!! 𝑋′! − 𝛼 !  ℒ(!!,!  !!! !!!)!!  !!! !!!   ) 
 
In searching the hyperparameter space for the best setting for 𝛼, a setting of 0.25 was found to have the best rate for 
estimator performance. Additional a tree depth of 5 was observed increase performance. 
 
 
 
Figure 5: Classifier performance vs. changes in alpha 
 
 
Figure 5: Classifier performance vs. changes in tree depth 
 
  
An additional feature of using a Decision tree-type classifier for this problem is that the feature importance can be 
obtained and measured using the information gain of the features. In this study, the class of top features ranked on 
importance were previous diagnoses, indicating that previous diagnoses of comorbidity have a strong predictive 
quality to drug resistance. In this study, the feature names were disguised for security purposes, however it would be 
interesting to evaluate in future work whether or not these diagnoses are correlated with different modes of 
causality, such as the gene variant hypothesis [3], which indicates that P-glycoprotein, encoded by the ABCB1 gene, 
might play a role in AED resistance.  
Conclusion 
This study examined data for epileptic patients to refine methodologies for predicting drug resistance. A 
presentation of results is available at :  https://youtu.be/3Cwj_EeMtLg 
The challenges around this project were in dealing with large datasets in cloud environments, where the data were 
not easily modeled using linear classifiers.  In this case, it was discovered that transforming patient features using 
Kernel PCA and an Ensemble of Gradient Boosted Trees were able to capture some signal in the data. In reviewing 
our second hypothesis, we can conclude that we can create predictions around which patients may be more at risk of 
developing drug resistance with a reasonable degree of accuracy. 
In reviewing hypothesis 1, clustering accuracy on raw features and features projected into lower dimensional spaces 
was not observed using the described methodologies. This section of the study did bring value, although we must 
reject the hypothesis under current methods attempted, as it was observed that using dimensionally reduced features 
improved classifier accuracy. 
Further work could entail working with undisguised features to examine relationships in past diagnoses in relation to 
future drug resistance in support of the gene variant hypothesis [3]. 
 
 
Supplemental Material 
• https://youtu.be/3Cwj_EeMtLg 
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